FEMALE HEALTH CO
SB-2, EX-5, 2000-09-21
FABRICATED RUBBER PRODUCTS, NEC
Previous: FEMALE HEALTH CO, SB-2, EX-3.2, 2000-09-21
Next: FEMALE HEALTH CO, SB-2, EX-10.55, 2000-09-21




                               September 21, 2000

The  Female  Health  Company
875  North  Michigan  Avenue
Suite  3660
Chicago,  Illinois  60611

Gentlemen:                       Re:     Registration  Statement  on  Form  SB-2

     We  have  acted  as  counsel  for  The  Female  Health Company, a Wisconsin
corporation  (the  "Company"),  in connection with the Company's registration of
650,000  shares (the "Shares") of its $.01 par value common stock at the request
of  three  selling  stockholders  (the  "Selling  Stockholders").

     In  such  capacity we have examined, among other documents, the Articles of
Incorporation  of the Company, as amended and the Registration Statement on Form
SB-2  to  be filed by the Company with the Securities and Exchange Commission on
or  shortly  after  the  date  of  this  letter covering the sale by the Selling
Stockholders  of  the  Shares.  Based  on  the  foregoing  and  such  additional
investigation  as  we  have  deemed necessary, it is our opinion that the Shares
have  been  validly  issued  and are fully-paid and nonassessable, except as set
forth  in  Wisconsin  Statutes  section  180.0622(2)(b),  as  interpreted, which
provides  that shareholders of the Company may be personally liable in an amount
equal  to  the par value of their shares for all debts owing to employees of the
Company  for  services  performed for the Company, but not exceeding six months'
service  in  any  one  case
 .
     We  consent  to  the  filing of a copy of this opinion as an exhibit to the
Registration  Statement  on  Form  SB-2  and  to the use of our name beneath the
caption  "Legal  Matters"  in  the prospectus forming a part of the Registration
Statement.
 .
                              REINHART,  BOERNER,  VAN  DEUREN,
                              NORRIS  &  RIESELBACH,  s.c.

                              BY     /s/  James  M.  Bedore
                                     ----------------------
                                          James M. Bedore





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission